Eckhardt Juergen
Transaction: 06/09/2026
BUY
Change
+21,000
Price
$1.23
Filing
06/11/2026
Type
BUY
Metagenomi, Inc. Common Stock
MGX • Biotechnology
$0.83
▲ +0.02 (+2.40%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$30.13M
Growth
101.6%
Cash Flow
2/5
Trend
Volatile
Evidence
Positive revenue growth · 101.6%Manageable debt level · 0.26Healthy liquidity · 7.22Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 13, 2026, 1:00 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$0.83
Change2.40%
Shares Out37.66M
Market Cap$30.13M
Enterprise Value$-52.82M
52W Range1.13 - 3.95
Beta0.67
P/E-0.32
P/S2.22
P/B0.27
P/FCF-0.35
EV/Sales-3.89
Price$0.83
Change2.40%
Shares Out37.66M
Market Cap$30.13M
Enterprise Value$-52.82M
52W Range1.13 - 3.95
Beta0.67
P/E-0.32
P/S2.22
P/B0.27
P/FCF-0.35
EV/Sales-3.89
EV/EBITDA0.56
EV/FCF0.62
Earnings Yield-310.23%
FCF Yield-284.78%
Dividend Yield0.00%
Gross Margin78.91%
Oper. Margin-3.81%
Profit Margin-3.49%
Debt/Eq0.26
Current Ratio7.22
Quick Ratio7.22
Revenue 5Y101.59%
Target$14.50
Target Upside1644.26%
Target Median$14.50
Target Range7.00 - 22.00
Volume91.28K
Avg Volume174.00K
EPS Surprise-0.01
Investment DNA
How strong this company looks for long-term investors
52
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
58/100
Price Attractiveness
Cheap or expensive today
89/100
Why this score▼
Positive revenue growth · 101.6%Manageable debt level · 0.26Healthy liquidity · 7.22Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 5 analyst votes · 2026-10-20
90/100
Bullish
Bullish
4
Hold
1
Bearish
0
Price Target
2026-08-13
Low
$7.00
Mean
$14.50
Median
$14.50
High
$22.00
Insider Transactions
Recent executive and insider activity
⚠ 1 high-volume insider sell detected
BJERKHOLT ERIC
Transaction: 06/09/2026
BUY
Change
+21,000
Price
$1.23
Filing
06/11/2026
Type
BUY
Dere Willard H
Transaction: 06/09/2026
BUY
Change
+21,000
Price
$1.23
Filing
06/11/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Eckhardt Juergen | BUY | +21,000 | $1.23 | 06/09/2026 | 06/11/2026 |
| BJERKHOLT ERIC | BUY | +21,000 | $1.23 | 06/09/2026 | 06/11/2026 |
| Dere Willard H | BUY | +21,000 | $1.23 | 06/09/2026 | 06/11/2026 |
| Reid Laurence | BUY | +17,400 | $1.23 | 06/09/2026 | 06/11/2026 |
| Wein Matthew | SELL | -558 | $1.30 | 06/05/2026 | 06/10/2026 |
| Irish Jian | SELL | -3,737 | $1.30 | 06/05/2026 | 06/10/2026 |
| Wapnick Pamela | SELL | -2,884 | $1.30 | 06/05/2026 | 06/10/2026 |
| Wapnick Pamela | BUY | +144,000 | $1.34 | 04/01/2026 | 04/03/2026 |
| Wapnick Pamela | BUY | +24,000 | Not reported | 04/01/2026 | 04/03/2026 |
| Wein Matthew | BUY | +68,000 | $1.34 | 04/01/2026 | 04/03/2026 |
| Wein Matthew | BUY | +11,000 | Not reported | 04/01/2026 | 04/03/2026 |
| Irish Jian | BUY | +276,000 | $1.34 | 04/01/2026 | 04/03/2026 |
| Irish Jian | BUY | +46,000 | Not reported | 04/01/2026 | 04/03/2026 |
| Irish Jian | SELL | -1,607 | $1.60 | 03/05/2026 | 03/09/2026 |
| Wein Matthew | SELL | -482 | $1.60 | 03/05/2026 | 03/09/2026 |
| Wapnick Pamela | SELL | -1,581 | $1.60 | 03/05/2026 | 03/09/2026 |
| Irish Jian | SELL | -228,462 | Not reported | 12/05/2025 | 03/09/2026 |
| Irish Jian | SELL | -1,602 | $1.77 | 12/05/2025 | 12/08/2025 |
| Wapnick Pamela | SELL | -1,576 | $1.77 | 12/05/2025 | 12/08/2025 |
| Wein Matthew | SELL | -199 | $1.77 | 12/05/2025 | 12/08/2025 |